Literature DB >> 12214132

Serum pentosidine as an indicator of Alzheimer's disease.

M Meli1, C Perier, C Ferron, F Parssegny, C Denis, R Gonthier, B Laurent, E Reynaud, J Frey, A Chamson.   

Abstract

Pentosidine, an advanced glycation end product (AGE), was assayed by HPLC in serum proteins from patients with Alzheimer type dementia (AD), patients with diabetes mellitus (D), and healthy (C) age-matched old subjects (mean age from each group = 84 years). Serum pentosidine was significantly different between the three groups despite similar renal function (serum creatinine < 160 micromol/L). In all groups of patients, pentosidine was independent of glycated hemoglobin (HbA1C) and the early glycation marker fructosamine and appeared to be an independent marker, mainly bound to serum albumin. Pentosidine could be an important factor useful for the diagnosis of Alzheimer's disease.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12214132     DOI： 10.3233/jad-2002-4203

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


  9 in total

1.  Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals.

Authors:  Michal Schnaider Beeri; Erin Moshier; James Schmeidler; James Godbold; Jaime Uribarri; Sarah Reddy; Mary Sano; Hillel T Grossman; Weijing Cai; Helen Vlassara; Jeremy M Silverman
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

2.  Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.

Authors:  Gary E Gibson; José A Luchsinger; Rosanna Cirio; Huanlian Chen; Jessica Franchino-Elder; Joseph A Hirsch; Lucien Bettendorff; Zhengming Chen; Sarah A Flowers; Linda M Gerber; Thomas Grandville; Nicole Schupf; Hui Xu; Yaakov Stern; Christian Habeck; Barry Jordan; Pasquale Fonzetti
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Advanced glycation end product level, diabetes, and accelerated cognitive aging.

Authors:  Kristine Yaffe; K Lindquist; A V Schwartz; C Vitartas; E Vittinghoff; S Satterfield; E M Simonsick; L Launer; C Rosano; J A Cauley; T Harris
Journal:  Neurology       Date:  2011-09-07       Impact factor: 9.910

4.  Clinical features of schizophrenia with enhanced carbonyl stress.

Authors:  Mitsuhiro Miyashita; Makoto Arai; Akiko Kobori; Tomoe Ichikawa; Kazuya Toriumi; Kazuhiro Niizato; Kenichi Oshima; Yuji Okazaki; Takeo Yoshikawa; Naoji Amano; Toshio Miyata; Masanari Itokawa
Journal:  Schizophr Bull       Date:  2013-09-23       Impact factor: 9.306

Review 5.  Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling.

Authors:  Sunil S Adav; Siu Kwan Sze
Journal:  Mol Brain       Date:  2016-11-03       Impact factor: 4.041

6.  Advanced glycation end products and cognitive impairment in schizophrenia.

Authors:  Akiko Kobori; Mitsuhiro Miyashita; Yasuhiro Miyano; Kazuhiro Suzuki; Kazuya Toriumi; Kazuhiro Niizato; Kenichi Oshima; Atsushi Imai; Yukihiro Nagase; Akane Yoshikawa; Yasue Horiuchi; Syudo Yamasaki; Atsushi Nishida; Satoshi Usami; Shunya Takizawa; Masanari Itokawa; Heii Arai; Makoto Arai
Journal:  PLoS One       Date:  2021-05-26       Impact factor: 3.240

7.  High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model.

Authors:  Irit Lubitz; Jan Ricny; Dana Atrakchi-Baranes; Chen Shemesh; Efrat Kravitz; Sigal Liraz-Zaltsman; Anna Maksin-Matveev; Itzik Cooper; Avshalom Leibowitz; Jaime Uribarri; James Schmeidler; Weijing Cai; Zdena Kristofikova; Daniela Ripova; Derek LeRoith; Michal Schnaider-Beeri
Journal:  Aging Cell       Date:  2016-01-19       Impact factor: 9.304

8.  Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia.

Authors:  Jinluan Chen; Sanne S Mooldijk; Silvan Licher; Komal Waqas; M Kamran Ikram; André G Uitterlinden; M Carola Zillikens; M Arfan Ikram
Journal:  JAMA Netw Open       Date:  2021-01-04

Review 9.  In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.

Authors:  Marialena Chrysanthou; Ignacio Miro Estruch; Ivonne M C M Rietjens; Harry J Wichers; Tamara Hoppenbrouwers
Journal:  Nutrients       Date:  2022-01-15       Impact factor: 5.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.